Shanghai Pharmaceuticals

Bio & Pharma Korea’s pharmaceutical exports set to top $10 bn, led by ‘K-M7’ champions

South Korea’s pharmaceutical exports are on course to surpass $10 billion this year, underscoring the country’s growing clout in the glo...

Bio & Pharma Hanmi breaks ground pharmaceuticals complex in Beijing

South Korea's Hanmi Pharmaceutical Co. said on Friday that Beijing Hanmi Pharm, its subsidiary in China, held the groundbreaking ceremony for a proj...

Business & Politics Latvian President Rinkēvičs seeks closer ties with S.Korea in bio, defense

Latvian President Edgars Rinkēvičs, who is on a four-day working trip to South Korea, said on Friday he hopes for deeper cooperation between the two...

Bio & Pharma Celltrion acquires Swiss pharmaceutical distributor iQone

South Korea's Celltrion Inc. said on Friday that it completed its acquisition of iQone Healthcare Switzerland, a Swiss pharmaceutical distributor, t...

Logistics CJ Logistics, Baropharm to cooperate on pharmaceutical logistics

South Korea's CJ Logistics said on Monday it signed a strategic partnership and exclusive pharmaceutical logistics contract with Baropharm, an integ...

Chemical Industry LG Chem targets functional cosmetics market with bio-materials

LG Chem Ltd., the world’s fourth-largest chemicals manufacturer, is targeting the functional cosmetics market with bio-materials derived from ...

Beauty & Cosmetics Cosmax China to build new headquarters in Shanghai

Cosmax Inc., South Korea's cosmetics original development and design manufacturer (ODM), will build a new headquarters in Shanghai's Xinzhuang Indus...

Chemical Industry Lotte Fine Chemical, Colorcon sign $740 mn distribution agreement

Lotte Fine Chemical Co., a subsidiary of South Korea's Lotte Chemical Corp., said on Monday that it signed a global distribution agreement with the ...

Pension funds NPS signals more say in Hanmi Pharmaceutical's family feud

South Korea’s National Pension Service is indicating more active involvement in the management of Hanmi Pharmaceutical Group embroiled in a ye...

Bio & Pharma IMBiologics transfers autoimmune disease drug tech to Huadong Pharma

South Korea's antibody-based biotech company IMBiologics announced on Friday that it signed a contract to transfer the technology of its autoimmune ...

Fashion F&F to expand Discovery brand across Asia

F&F Co., a South Korean clothing company, said on Monday it signed an exclusive deal with Warner Bros. Discovery (WBD) to bring the outdoor bran...

Shipping & Shipbuilding HMM opens Shanghai-Mexico container route

South Korea's HMM Co. announced on Monday that it launched a new Far East Latin America Express (FLX) container service bound for Mexico.The service...

Corporate governance Korea’s Hanmi family feud to end as key shareholder mediates

South Korean Hanmi Pharmaceutical Group’s founding family is set to conclude an ongoing feud as the group’s top individual shareholder h...

Bio & Pharma GC Biopharma exports Alyglo to US

South Korea’s major pharmaceutical company GC Biopharma Corp. announced on Monday that it shipped the initial volume of Alygro, its immunoglob...

Bio & Pharma LG Chem launches Synovian in China

South Korea's LG Chem Ltd. announced on Wednesday that it launched its homegrown new drug for osteoarthritis Synovian (marketed in China as Hyruan O...

Bio & Pharma Daewoong, Indonesia's IPB to co-research on primate

South Korea's Daewoong Pharmaceutical Co. announced on Thursday that it signed a contract with Indonesia's Bogor Agricultural University (Institut P...

Beauty & Cosmetics Cosmax China participates in Shanghai Beauty Expo

Cosmax Inc., South Korea's largest cosmetics manufacturer specializing in original design manufacturing (ODM), on Thursday that its Chinese subsidia...

Corporate governance Hanmi to fire founder's wife, entering new round of family feud

South Korea’s Hanmi Pharmaceutical Group is set to enter a new chapter of an ongoing family feud less than two months after the founding famil...

Corporate bonds SK Chemicals' bond oversubscribed with $526 mn demand

SK Chemicals Co., a unit of South Korea’s No. 2 conglomerate SK Group, is set for a successful debt issue as the company’s bond sale has...

Bio & Pharma KKR, Hanmi heirs likely to join hands for controlling stake

The two sons of Hanmi Pharmaceutical Group’s founding family, who were approved as board members of the holding firm Hanmi Science Co. at its ...

Fashion LF’s fashion brand Dunst teams up with E-Land for China push

South Korean clothing company LF Corp. said on Monday that its street fashion brand Dunst will build an offline presence in China in partnership wit...

Bio & Pharma Medytox to supply $73 mn botulinum toxin to Brazilian firm

South Korea's biopharmaceutical firm Medytox Inc. announced on Tuesday that it signed a contract with Brazilian pharmaceutical company Blau Farmaceu...

Logistics Samsung SDS gets CEIV Pharma certification

South Korea's Samsung SDS Co. said on Wednesday that it has achieved the Center of Excellence for Independent Validators in Pharmaceutical Logistics...

Bio & Pharma Daewoong Pharmaceutical digitizes DB of 800 mn chemical compounds

South Korea's Daewoong Pharmaceutical announced on Monday that it has established a drug development system Daewoong AI System (DAISY) which combine...

Batteries LG Chem sees up to 25% battery sector growth in 2024: report

South Korea’s LG Chem Ltd., the parent of the world’s second-largest electric vehicle battery maker LG Energy Solution Ltd., expects up ...

Mergers & Acquisitions OCI-Hanmi merger to create Korea’s Bayer: OCI Chairman

Merging into one team, OCI Group and Hanmi Pharmaceutical Group will leap forward to be a global novel drug manufacturing and biotechnology innova...

Bio & Pharma LG Chem out-licenses obesity drug candidate to US firm

LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...

Bio & Pharma J&J seeks US, European approval for drug developed with Yuhan

Global healthcare giant Johnson & Johnson is seeking approval for a lung cancer drug developed with Yuhan Corp., bringing the South Korean pha...

Bio & Pharma HK inno.N reveals differentiated clinical results for K-CAB

South Korean bio-health company HK inno.N has been expanding its market by steadily announcing differentiated clinical results for its gastroesophag...

Bio & Pharma Samsung Biologics reaches record-breaking annual orders

Samsung Biologics Co., the world’s top contract manufacturing organization (CMO) by capacity, surpassed the annual contract manufacturing orde...